Hypertension is a leading modifiable cause of cardiovascular morbidity and mortality and highly prevalent worldwide. 1,2 The development of hypertension is complex and may involve many factors including blood volume, vascular response, neurohormonal regulation, physical inactivity, and genetic variations. 3 Although interventions against these risk factors has improved hypertension control rate, 4 hypertension still remains an important public health challenge. Some unknown risk factors for hypertension need to be studied to improve hypertension prevention and control.
Hypertension is a leading modifiable cause of cardiovascular morbidity and mortality and highly prevalent worldwide. 1, 2 The development of hypertension is complex and may involve many factors including blood volume, vascular response, neurohormonal regulation, physical inactivity, and genetic variations. 3 Although interventions against these risk factors has improved hypertension control rate, 4 hypertension still remains an important public health challenge. Some unknown risk factors for hypertension need to be studied to improve hypertension prevention and control.
Hypertension fundamentally reflects the failure of the body to adequately regulate salt and water balance insuring the maintenance of a normal blood pressure. 5, 6 Natriuretic peptides play a key role in regulation of salt and water balance and volume homeostasis due to their natriuretic/diuretic and vasodilatory actions. 7 Cell-and animal-based studies have shown that human corin, a type II transmembrane serine protease highly expressed in the heart, 8, 9 played a physiological role in activation of natriuretic peptides. 10, 11 Furthermore, a recent animalbased study found that knockout of the corin gene abolished atrial natriuretic peptide generation and subsequently caused increased blood pressure in mice. 11 These findings suggest an association between corin and hypertension; however, the association is limited studied in humans. Recently, corin gene variants were found to be associated with hypertension among African Americans. 12 Moreover, clinical studies have examined circulating soluble corin in some disease states, such as heart failure, 13 chronic kidney disease, 14 and pregnant Association Between High Serum Soluble Corin and Hypertension: A Cross-Sectional Study in a General Population of China hypertension, 15 although molecular forms and biological function of soluble corin in the circulation have not been well characterized. To date, the association between circulating soluble corin and hypertension still lacks population-based evidence which critically promotes translation from basic research to clinical and preventive practice. Here, we aimed to study the association in a general population of China.
METHODS

Study participants
We conducted a cross-sectional study in a traditional but economically developed district of Suzhou from January to May 2010. The participants were selected via multiphase cluster random sampling. From the total 20 urban communities and 19 rural villages in the district, 4 urban communities and 4 rural villages were randomly selected as the research fields. The subjects were selected from the 8 selected study fields. The selection criteria were to meet all of the followings: (i) age: ≥30 years, (ii) ethnicity: Han. There were a total of 3,061 eligible residents in the study fields, but only 2,706 (participating rate: 88%) persons participated in this study. The exclusion criteria were to meet one of the followings: (i) having clinical suspicion of diseases which may cause secondary hypertension (e.g., renal artery stenosis, coarctation, glomerulonephritis, pyelonephritis, pheochromocytoma, Cushing's syndrome, Conn's syndrome), (ii) self-reported history of coronary heart disease, stroke, or tumors, (iii) self-reported thyroid or parathyroid diseases, (iv) being pregnant. After excluding 101 persons meeting the exclusion criteria and 107 ones for lacking blood samples, 2,498 participants were finally included in current analysis. This study was approved by the Soochow University Ethics Committee. Written informed consent was obtained from all study participants.
Data collection
Data on demographic information, lifestyle risk factors, and personal medical history were collected with standard questionnaires in Chinese language administered by trained staff. Cigarette smoking was defined as having smoked at least 1 cigarette per day for 1 year or more and reported current smoking. Alcohol consumption was defined as consuming any type of alcohol beverage at least once per week during the last 3 years. Body weight and height were measured using a regularly calibrated stadiometer and balance-beam scale with participants wearing light clothing and no shoes. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Waist circumference was measured at the level of 1 cm above the umbilicus. Three consecutive sitting blood pressure measurements (3 minutes between each) were taken by trained staff using a standard mercury sphygmomanometer according to a standard protocol, 16 after the subjects had been resting for at least 5 minutes in the morning. The first and fifth Korotkoff sounds were recorded as systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively. The mean of the 3 records was used in analysis. Hypertension was defined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg and/or use of antihypertensive medication in the last 2 weeks. 1 Blood samples were obtained by venipuncture in the morning after a requested overnight fast (at least 8 hours). All plasma and serum samples were frozen at −80 °C until laboratory testing. Total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) as well as fasting plasma glucose (FPG) were examined for all participants. All the biochemical indexes were analyzed enzymatically on Hitachi 7020 automatic biochemical analyzer using commercial reagents (KANGXIANG MEDICAL APPliANCE, Shanghai, P.R. China). Intra-and interassay coefficients of variation were less than 2% and 4%, respectively. Soluble corin was reported to be stable in blood samples frozen at −80 °C after several cycles of freezing and thawing. 17 We used a quantikine human corin immunoassay (R&D Systems, Minneapolis, MN. Catalog: DCRN00; Lot: 313116) to test soluble corin levels in serum. All the samples were processed in a duplicate assay. A standard curve was constructed and from which corin concentrations of unknown samples were determined. Intra-and interassay coefficients of variation were less than 2.7% and 6.3%, respectively.
Statistical analysis
Statistical analysis was conducted using SAS statistical software (version 9.1, Cary, NC). Clinical characteristics of hypertensive and nonhypertensive participants were compared using a Student's t-test, Wilcoxon rank-sum test, or the chi-square test as appropriate. For lacking a normal distribution, the average level of serum corin was compared between the 2 groups using a Wilcoxon rank-sum test. Logtransformation was then used to approximate the distribution of data to normal (skewness was improved from 1.09 to 0.04). A Pearson correlation analysis was used to evaluate the correlation between blood pressure and log-transformed corin in total participants. In order to eliminate the probable effect of antihypertensive drugs, the correlation was further evaluated after excluding individuals under antihypertensive medications. In addition, the correlation was examined in nonhypertensive individuals to assess the probable effect of serum corin on blood pressure elevation. Then, univariate and multivariate nonconditional logistic regression analysis were performed to assess the association between serum soluble corin and hypertension using log-transformed corin as an independent variable for the large variance. In addition, all participants were categorized into 4 groups according to the quartiles of serum corin. Odds ratios (OR) and 95% confidence intervals of hypertension were calculated for upper quartiles of corin with the lowest quartile as a reference. The model fit was assessed using a Hosmer-Lemeshow goodness-of-fit test. Trends in the ORs of hypertension across increasing corin categories were determined, modeling corin category as an ordinal variable. The potential covariates such as age, gender, cigarette smoking, alcohol consumption, family history of hypertension, BMI, TG, LDL-C, HDL-C, and FPG were included in the multivariate model. In order to eliminate the probable effect of antihypertensive drugs, the logistic model was repeated after excluding hypertensive individuals receiving antihypertensive medications. Furthermore, participants were categorized into 2 groups according to serum soluble corin: high corin group (over the median level: 1,689.20 pg/ml) and low corin group (below the median level). The prevalence and OR of hypertension associated with high serum soluble corin were assessed in 10 prespecified subgroups by age, sex, cigarette smoking, alcohol consumption, BMI, TC, TG, LDL-C, HDL-C, and FPG in unadjusted logistic regression models. A 2-tailed P value less than 0.05 was considered statistically significant.
RESULTS
Clinical characteristics
A total of 2,498 participants, including 962 males and 1536 females, were included in current analysis and the average age was 53 years old ranged from 30 to 80 years. Among them, 1,109 (44.40%) participants were hypertensive and 623 participants were receiving antihypertensive medications. There were 582 (23.30%) cigarette smokers, 465 (18.61%) alcohol consumers, and 673 (26.94%) participants reporting a family history of hypertension in our cohort. The average level of serum corin was 1,810.42 pg/ml with a range of 373.39-5,335.65 pg/ml. The characteristics of the participants were presented in Table 1 . Participants with hypertension were more likely to be older, males, cigarette smokers, alcohol consumers and have a family history of hypertension, and have higher levels of BMI, waist circumference, TC, TG, LDL-C, and FPG as well as a lower level of HDL-C compared with those without hypertension (all P < 0.01). The median of serum soluble corin or mean of log-transformed serum corin were significantly higher in the participants with hypertension than that in those without hypertension (P < 0.01). With increase of serum soluble corin levels, both SBP and DBP increased (Supplementary Table 1 ).
Correlation between serum corin and blood pressure
Pearson correlation analysis showed a significant linear relation between blood pressure and serum corin. As shown in Figure 1 , SBP and DBP positively correlated to log-transformed serum corin, with a significant coefficient of 0.153 (P < 0.01) and 0.243 (P < 0.01) respectively. Although whether antihypertensive drugs have an effect on serum corin was unknown, the probable influence may be caused by antihypertensive drugs. Therefore, the correlation was further analyzed after excluding participants under antihypertensive medications. As shown in Figure 2 , SBP (r = 0.143, P <0.01) and DBP (r = 0.245, P <0.01) still significantly correlated to log-transformed corin in participants not receiving any antihypertensive drugs. The correlation was additionally examined and remained in nonhypertensive individuals (Figure 3) , indicating an association of serum corin with progressive blood pressure elevation.
Association between serum soluble corin and hypertension
As shown in Table 2 , univariate analysis showed a significant association between log-transformed serum corin and hypertension (OR = 4.00, P < 0.01). After adjustment for age, gender, cigarette smoking, alcohol consumption, family history of hypertension, BMI, TG, LDL-C, HDL-C, and FPG, Results are expressed with median (interquartile range) unless otherwise noted. Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FHH, family history of hypertension; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WC, waist circumference.
the association remained significant (OR = 2.01, P < 0.01) although the OR decreased in comparison with the unadjusted OR of 4.00. When participants were categorized into 4 groups according to quartiles of serum soluble corin, ORs of hypertension for upper quartiles were calculated with the lowest quartile as a reference. In the univariate analysis, the OR of hypertension for participants in the third and fourth quartile had 1.78 and 3.31 times the OR of hypertension than individuals in the lowest quartile (all P values < 0.01). ORs of hypertension positively increased with serum corin levels (P for trend <0.01). After multivariate adjustment, participants in the third (OR = 1.43, P = 0.07) and fourth (OR = 1.96, P < 0.01) quartiles had significantly increased odds of hypertension compared to participants in the lowest quartile. ORs of hypertension still positively and significantly increased with serum corin levels (P for trend < 0.01). As shown in Subgroup analysis on the association between serum soluble corin and hypertension
As shown in Table 4 , the prevalence of hypertension in high corin group was higher than that in low corin group in all subgroups. Compared with low corin group, ORs of hypertension for high corin group were significant in subgroups by age, BMI, TC, LDL-C, and FPG (all P < 0.05). In subgroups by sex, cigarette smoking, alcohol consumption, TG, and HDL-C, ORs of hypertension were significant in female participants, those who reported no cigarette smoking, no alcohol consumption, and those who had a normal level of TG and HDL-C, whereas not significant in males, alcohol consumers, cigarette smokers, or those who had an abnormal level of TG or HDL-C.
Serum soluble corin and antihypertensive medication
Of the 1,109 hypertensive participants, 623 individuals were on antihypertensive medications and 486 were not on any drugs. As shown in Figure 4 , the median levels of serum soluble corin were 1,835.04 and 1,840.92 pg/ml in treated and untreated hypertensive individuals, respectively. There was no significant difference in serum soluble corin between treated and untreated hypertensive participants (P = 0.73). Serum corin level was higher in both untreated (P < 0.01) and treated (P < 0.01) participants with hypertension compared to those without hypertension. Among the 623 hypertensive participants under treatment, there were 233 participants whose blood pressures were well controlled (lower than 140/90 mm Hg) and 390 ones whose blood pressures were poorly controlled (higher than 140/90 mm Hg). The median level of serum soluble corin was lower in individuals (1,785.38 pg/ml) whose blood pressures were well controlled than that in those (1,876.02 pg/ml) whose blood pressures were poorly controlled (P = 0.02). When the quartiles of serum corin were included in logistic models, a Hosmer-Lemeshow goodness-of-fit test was applied to examine the model fit (X 2 = 4.53, P = 0.01 for unadjusted model; X 2 = 1.02, P = 0.23 for adjusted model).
Abbreviations: CI, confidence interval; OR, odds ratio. a Adjusted for age, gender, current smoking, alcohol consumption, family history of hypertension, body mass index, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose. When the quartiles of serum corin were included in logistic models, a Hosmer-Lemeshow goodness-of-fit test was applied to examine the model fit (X 2 = 3.82, P = 0.02 for unadjusted model; X 2 = 0.99, P = 0.66 for adjusted model).
Abbreviations: CI, confidence interval; OR, odds ratio. a Adjusted for age, gender, current smoking, alcohol consumption, family history of hypertension, body mass index, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose.
DISCUSSION
We conducted a cross-sectional study designed to explore the relationship between serum soluble corin and prevalent hypertension in 2,498 adults in Suzhou, China. Unexpectedly, we did not find a phenomenon of serum soluble corin reduction in hypertensive individuals compared with nonhypertensive ones in this study. Our findings, on the contrary, showed that participants with hypertension had an increased serum soluble corin compared to those without hypertension. OR of hypertension increased with the level of serum soluble corin after multivariate adjustment. Furthermore, subgroups analysis showed that the association between serum soluble corin and hypertension remained significant in almost every stratification. Our results showed a significant and positive association between serum soluble corin Low corin was defined as less than the median level of serum corin concentration, corin <1,689.20 pg/ml; high corin was defined as over the median level of serum corin concentration, corin ≥1,689.20 pg/ml. In the multivariate models, confounding factors such as age, gender, current smoking, alcohol consumption, family history of hypertension, body mass index, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and fasting plasma glucose were included unless the variable was used as a subgroup variable.
Abbreviations: CI, confidence interval; OR, odds ratio. a Subgroups by blood lipids was based on the recommendations from Working Group on dyslipidemia in China: optimal and abnormal. b Subgroups by fasting plasma glucose was based on the American Diabetes Association's stands of medical care in diabetes 2014: optimal and hyperglycemia. and hypertension. Therefore, these findings did not provide a population-based supportive evidence for the hypothesis from cell-and animal-based studies 6, 7, 11 that increased corin level probably lowered blood pressure, our results appeared to indicate that relation of serum soluble corin to hypertension in humans is more complex than in cell and animal experiments. Our findings seemed to show that increased serum soluble corin might be a risk factor or a marker for hypertension in humans.
Soluble corin was measured by the enzyme-linked immunosorbent assays in most studies. 13, 15, [18] [19] [20] At the present study, we also used commercially enzyme-linked immunosorbent assays to measure the serum soluble corin for all participants. The range of serum corin (373.39-2,833.35 pg/ ml) detected in nonhypertensive individuals in our study was similar to that (296-2,590 pg/ml) in previous report. 17 Corin, a type II transmembrane serine protease highly expressed in the heart, 6 was found to play a role in regulation of blood pressure and cardiac function by activating the natriuretic peptides. 21, 22 Some studies have suggested that corin converts proatrial natriuretic peptide to active natriuretic peptide, 10, 11, 22 active natriuretic peptide stimulates production of intracellular cyclic guanosine monophosphate, [22] [23] [24] leading to natriuresis, diuresis, and vasodilatation, thereby decreasing blood pressure through reduction of intravascular volume and systemic vascular resistance. 25, 26 Furthermore, Chan et al. 11 found that proatrial natriuretic peptides activation was abolished in corin gene knockout mice, and these corin-deficient mice developed hypertension, implying that corin is a physiological proatrial natriuretic peptide convertase and plays a critical role in maintaining normal blood pressure.
Recently, corin was found to be shed from the cardiomyocyte surface by metalloproteinase-mediated hydrolysis and corin autocleavage, 27 and shed corin molecules could enter the circulation. Soluble corin was detectable and found to have the same efficiency in activation of atrial natriuretic peptide as the membrane-bound corin. 24 As a result, it became feasible to study soluble corin in populations. Few small sampled case-control studies [13] [14] [15] have been conducted in humans to study relationship between corin and pregnant hypertension and preeclampsia. Cui et al. 28 found that levels of corin messenger RNA and protein in uteruses were significantly lower in preeclamptic women than in normal pregnancies, they also found that plasma corin levels were higher in preeclamptic patients than nonpregnant or normal pregnant women. Thus, they speculated that plasma soluble corin levels did not reflect that in tissues, plasma corin was likely derived from the heart, where corin expression was increased in response to high blood volume and pressure in pregnancy. Zaki et al. 15 compared 60 pregnant females with gestational hypertension to 28 healthy pregnant females of the same gestational period in regarding to plasma soluble corin level. Their findings showed that plasma soluble corin was significantly increased in the women with gestational hypertension. However, there have been no studies on relationship between corin level and hypertension in a large sample of general population. To date, a number of single-nucleotide polymorphisms in the human corin gene have been identified. Two nonsynonymous single-nucleotide polymorphisms (T555I/Q568P) in a minor corin allele have been found to be more common in African Americans than Caucasians. 12 In epidemiological studies, this minor corin allele was associated with higher blood pressure and an increased risk for prevalent hypertension as well as an enhanced cardiac hypertrophic response to high blood pressure among blacks. 12, 25 Impairment of process that corin convert pronatriuretic peptide to natriuretic peptide may be the cause of increased risk of prevalent hypertension among blacks with minor corin T555I (Q568P) allele, as suggested recently from the report that knockout of the corin gene results in higher blood pressure and cardiac hypertrophy in mice. 11 However, they did not examine the levels of corin or atrial natriuretic peptide.
As a physiological activator of natriuretic peptides, 10,11 an increased corin level has been suggested to indicate a higher rate of active natriuretic peptides production. Some studies have reported that natriuretic peptides were increased in individuals with hypertension 29, 30 and predicted incident cardiovascular events. 31 Similarly, in our study, serum soluble corin levels significantly increased in individuals with hypertension, furthermore, levels of serum soluble corin were lower in hypertensive individuals whose blood pressure was well controlled than those whose blood pressure were not well controlled. The reason why the findings from population-based studies are contradictory to those from animal-based studies is still unknown at present. Probable explanation is that increased blood pressure, retention of sodium, and volume overload of the heart in hypertensives stimulate secretion of corin in feedback to facilitate conversion of proatrial natriuretic peptide to active natriuretic peptide. We conjecture that activity of corin may be low in individuals with hypertension although level of corin is increased. It is more important that activity of corin is measured to study the relationship between corin and hypertension. However, whether soluble corin is increased in hypertensive individuals in comparison with normotensive ones remain to be studied from various populations in future.
To our knowledge, this is the first study to investigate the association between serum soluble corin and hypertension in a general population. In our study, we excluded the participants who had a history of coronary heart disease, stroke, or tumors, as well as other conditions that may cause secondary hypertension. In addition to serum corin, we obtained major conventional risk factors for hypertension, such as blood lipids, blood glucose, alcohol consumption, and cigarette smoking. In data analysis, all conventional risk factors obtained were controlled to reduce their confounding effects, and subgroups analysis was conducted. Nevertheless, several limitations should be acknowledged. First, a causal relationship between serum soluble corin and hypertension cannot be inferred because of the cross-sectional nature of the study design. Prospective cohort study is needed to confirm the causal relationship between them. Second, the diagnosis of hypertension was mainly based on the casual blood pressure which may lead to misclassification of a part of individuals in a certain extent. Nevertheless, a standardized causal blood pressure measurement was reported to be similar to ambulatory blood pressure monitoring. 32 Lastly, we did not examine atrial natriuretic peptide level, which can reflect the activity of corin. In summary, we found an increased level of serum soluble corin in participants with hypertension in comparison with those without hypertension. Further study of the association between soluble corin in the circulation and hypertension should be warranted among various populations.
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